+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
FEMALE
ID03111173

Feasibility Study Using Holter ECG to Capture Fetal Heart Activity in Pregnant Women from 32 Weeks to Full Term

Led by University of Washington · Updated on 2024-01-18

50

Participants Needed

1

Research Sites

78 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating if it is possible to capture a fetal electrocardiogram ECG signal using a Holter ECG device in pregnant women between 32 weeks gestation and full term. This study aims to compare this approach with a standard Doppler Fetal Heart Rate FHR device, using a fetal EEG monitor to obtain raw FHR data. The goal is to validate an algorithm for deriving fetal heart rate from abdominal ECG signals. Participants will have a Holter ECG device with four electrodes attached to the abdomen, along with a standard Doppler FHR device connected to a fetal EEG monitor. The Holter device records for about 30 minutes while the participant rests lying down. This procedure is done after routine antepartum testing and excludes women in active labor. During the study, researchers will monitor the fetal ECG signals and compare them to the standard FHR recordings. They will assess the successful extraction of fetal ECG from the maternal abdominal ECG over 12 months. Participants will undergo only one recording session, and no additional treatments or long-term follow-up are involved.

CONDITIONS

Brief Title

Can Conventional ECG Technology Capture Fetal Cardiac Activity?

Research Team

M

Martin G Frasch, MD, PhD

A

Amy Gest, MPA

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here